Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amitabha Mazumder

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Best Practice & Research. Clinical Haematology|September 26, 2006
Thalidomide and lenalidomide in multiple myelomaAmitabha Mazumder, Sundar Jagannath
Cancer Immunology, Immunotherapy : CII|February 21, 2003
Generation of tumor cell lysate-loaded dendritic cells preprogrammed for IL-12 production and augmented T cell responseZsuzsa Vegh, Amitabha Mazumder
Cancer Cell International|September 18, 2002
Primary Research: Short Communication: Evidence Supporting Rare AIDS-Kaposi's Sarcoma Metastasis In Keeping With Their Vascular Endothelial EvolutionMahruf U Rahman, Amitabha Mazumder
The National Medical Journal of India|May 31, 2018
Interleukin-2 and lymphokine activated killer cell phenomenon: Biological considerations and clinical applicationsBishan S Charak, Amitabha Mazumder
Biologics : Targets & Therapy|December 1, 2010
Proteasome inhibition and its therapeutic potential in multiple myelomaAjai Chari, Amitabha Mazumder, Sundar Jagannath
Clinical Lymphoma, Myeloma & Leukemia|April 8, 2010
Vorinostat plus bortezomib for the treatment of relapsed/refractory multiple myeloma: a case series illustrating utility in clinical practiceAmitabha Mazumder, David H Vesole, Sundar Jagannath
Clinical Lymphoma & Myeloma|November 21, 2007
Liver involvement in multiple myelomaMeghana S Bhandari, Amitabha Mazumder, David H Vesole
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 18, 2013
Adenosine regulates bone metabolism via A1, A2A, and A2B receptors in bone marrow cells from normal humans and patients with multiple myelomaWenjie He, Amitabha Mazumder, Tuere Wilder, et al.
Clinical Lymphoma & Myeloma|July 25, 2008
Association between renal cell carcinoma and plasma cell dyscrasias: a case series of six patientsMeghana S Bhandari, Amitabha Mazumder, Sundar Jagannath, et al.
Clinical Lymphoma & Myeloma|October 10, 2006
Engraftment syndrome after hematopoietic stem cell transplantation in multiple myelomaJed Abraham Katzel, Amitabha Mazumder, Sundar Jagannath, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Best Practice & Research. Clinical Haematology|September 26, 2006
Thalidomide and lenalidomide in multiple myelomaAmitabha Mazumder, Sundar Jagannath
Cancer Immunology, Immunotherapy : CII|February 21, 2003
Generation of tumor cell lysate-loaded dendritic cells preprogrammed for IL-12 production and augmented T cell responseZsuzsa Vegh, Amitabha Mazumder
Cancer Cell International|September 18, 2002
Primary Research: Short Communication: Evidence Supporting Rare AIDS-Kaposi's Sarcoma Metastasis In Keeping With Their Vascular Endothelial EvolutionMahruf U Rahman, Amitabha Mazumder
The National Medical Journal of India|May 31, 2018
Interleukin-2 and lymphokine activated killer cell phenomenon: Biological considerations and clinical applicationsBishan S Charak, Amitabha Mazumder
Biologics : Targets & Therapy|December 1, 2010
Proteasome inhibition and its therapeutic potential in multiple myelomaAjai Chari, Amitabha Mazumder, Sundar Jagannath
Clinical Lymphoma, Myeloma & Leukemia|April 8, 2010
Vorinostat plus bortezomib for the treatment of relapsed/refractory multiple myeloma: a case series illustrating utility in clinical practiceAmitabha Mazumder, David H Vesole, Sundar Jagannath
Clinical Lymphoma & Myeloma|November 21, 2007
Liver involvement in multiple myelomaMeghana S Bhandari, Amitabha Mazumder, David H Vesole
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 18, 2013
Adenosine regulates bone metabolism via A1, A2A, and A2B receptors in bone marrow cells from normal humans and patients with multiple myelomaWenjie He, Amitabha Mazumder, Tuere Wilder, et al.
Clinical Lymphoma & Myeloma|July 25, 2008
Association between renal cell carcinoma and plasma cell dyscrasias: a case series of six patientsMeghana S Bhandari, Amitabha Mazumder, Sundar Jagannath, et al.
Clinical Lymphoma & Myeloma|October 10, 2006
Engraftment syndrome after hematopoietic stem cell transplantation in multiple myelomaJed Abraham Katzel, Amitabha Mazumder, Sundar Jagannath, et al.
Pageof 5